Lymphatic Filiariasis (LF)
GSK is an active partner in one of the world’s biggest and boldest public health initiatives the international effort led by the World Health Organisation (WHO) to rid the world of Lymphatic Filiariasis (otherwise known as elephantiasis). Our global commitment is to donate 600 million tablets of the required drug each year until LF is eliminated. GSK Nigeria, in partnership with our parent company, is responsible for the coordination of the donation to beneficiaries in the country.
African Family Nutrition Website
As part of our drive to improve the quality of human life, GSK launched a website tagged ‘African Family Nutrition’, which is a one-stop for nutrition queries. The objective of this website is to ensure that the right knowledge about children’s nutrition is provided to mothers through experts. This knowledge is made available through integrated (online and offline) digital channels.
In 2015, GSK sponsored the project plus in conjunction with Pharmacists Council of Nigeria (PCN). Project Plus is an initiative that is aimed at fighting product counterfeiting and also to ensure that Nigerians at the grassroots have access to original drug products. Project Plus seeks to tackle the menace of counterfeit and poor quality medicines in Nigeria by educating Patient Medicine dealers and sellers.